“ Many pundits I liaise with hail Professor Kaumaya’s PD1 vaccine as a replacement for Merck’s Keytruda, given its exceptional results in a recent and ongoing Phase 1 trial with lung cancer patients in Melbourne Australia.”
Big call Ben, that would value PD1 Vax at a crazy number like US$100. Or more even because it’s probably so much more than Kaytruda?
Wonder if we’ll ever do a combo trial using our B Cell Tech with our CF33 tech?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.3¢ | 1.2¢ | $179.4K | 14.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 15731879 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3463196 | 20 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |